Is anal tamponade worthwhile after Milligan-Morgan hemorrhoidectomy? A randomised controlled trial

Is anal tamponade worthwhile after Milligan-Morgan hemorrhoidectomy? A randomised controlled trial - Tamponade trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00004568

Enrollment

100

Registered

2012-11-27

Start date

2011-03-29

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K64.1 K64.2

Interventions

Group 1: After Milligan-Morgan hemorrhoidectomy a conventional anal tampon is inserted into the anal canal. After the completion of surgery, the tampon is placed in the patients anorectal transition z

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Hemorrhoids of 2nd, 3rd or 4th degree; indication of Milligan-Morgan hemorrhoidectomy

Exclusion criteria

Exclusion criteria: Non-elective surgery; known hemorrhagic disorders; anticoagulative medication within the last 7 days; previous colorectal carcinoma in patient's history; relevant anorectal comorbidity; neuromuscular disease interfering with pain recordings; missing written informed consent

Design outcomes

Primary

Measure	Time frame
The primary outcome measure is maximum postoperative pain. Patients will be interviewed on the evening of the first postoperative day. The patients records maximum pain using a numerical rating scale (NRS) ranging from 0 to 10.	—

Secondary

Measure	Time frame
Local complication rate, bleeding rate, number of dressing or napkin changes, length of hospital stay	—

Countries

Germany

Contacts

Public ContactMike Ralf Langenbach

Helios St.Elisabeth Klinik Oberhausen

ob-allgemeinchirurgie@helios-kliniken.de0208-85064001

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 3, 2026